	Intraoperative NIR-II fluorescence guidance for precise tumor margin assessment and maximized tissue preservation in breast surgery. Breast Cancer Res Zhang Y, Li K, Zhang S, Yang H, Wang H, Chen Y, Feng Y, Chen D, Zhang Z, Wang S. PMID: 42374464 [PubMed - as supplied by publisher]
	Gastric-type Histology Independently Predicts Poor Survival in Surgically-treated Cervical Adenocarcinoma. Anticancer Res Kang OJ, Kim Y, Nam SH, Lee SW, Park JY, Kim DY, Kim JH, Kim JH. PMID: 42373253 [PubMed - indexed for MEDLINE]
	Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study. Anticancer Res Nakai M, Yoshida K, Morita H, Kawamura Y, Matsumoto T, Gohara Y, Hoshino N, Tonomura N, Banba M, Kaneko M, Tachibana M, Fukushima T, Hosokawa H, Mura T, Yabuki T, Watanabe S, Miyawaki T, Hidaka N, Tanaka M. PMID: 42373244 [PubMed - indexed for MEDLINE]
	Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases. Lancet Oncol Fan Y, Zhang H, Tang S, Toi M. PMID: 42372753 [PubMed - indexed for MEDLINE]
	Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancer. Lancet Oncol Kaidar-Person O, Weltens CG, Fortpied C, Scheijmans LJEE, Kirkove CY, Budach V, Peignaux-Casasnovas K, Valli M, Peters M, van der Leij F, Rivera S, Weidner N, van den Bongard DHJG, Linsenmeier C, Abdah-Bortnyak R, Hosni S, Koiter E, Engelen AM, Baten A, Champezou L, Fourquet A, Bartelink HGMM, Struikmans H, Poortmans PMP, EORTC Radiation Oncology and Breast Cancer Groups. PMID: 42372743 [PubMed - indexed for MEDLINE]
	Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study. Lancet Oncol Mauritz AJW, de Munck L, Simons JM, Verloop J, van Dalen T, Elkhuizen PHM, Scholten A, Houben RMA, van Leeuwen-Stok AE, Linn SC, Pijnappel RM, Poortmans PMP, Strobbe LJA, Wesseling J, Voogd AC, Boersma LJ. PMID: 42372742 [PubMed - indexed for MEDLINE]
	Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial. Lancet Oncol Seefat RL, Vliek SB, de Jong VMT, Balduzzi S, Mandjes IA, Retèl VP, Eekhout I, Delfos M, Schot M, Holtkamp MJ, van Rosmalen MM, Leeneman B, Blommestein H, Huitema ADR, Rosenberg EH, Nederlof PM, Chan TWS, van Rhenen A, Wondergem MJ, Schaap NPM, Snijders TJF, Van der Poel MWM, Plattel WJ, van Werkhoven E, van Tinteren H, Smidt ML, Wesseling J, Jonkers J, Rottenberg S, Vrancken Peeters MTFD, Voermans C, Maduro JH, Kroep JR, Schroder CP, Kuip EJM, Gonçalves A, Nuver J, Wymenga ANM, Bijlsma RM, van der Wall E, Konings IRHM, Tjan-Heijnen VCG, Jongen-Lavrencic M, Jager A, Linn SC. PMID: 42372741 [PubMed - indexed for MEDLINE]
	Acidosis-associated gene signature defines novel subtypes and dual-target therapeutic candidates in breast cancer. J Transl Med Li Y, Wu D, Shi Z, Luo Q, Deng W, Liu Q, Lu A, Chen W, Qin G, Guan D. PMID: 42374456 [PubMed - as supplied by publisher]
	Temporal deep learning for 28-day mortality prediction in critically ill ovarian cancer patients: a multicenter development and validation study using hourly vital signs. J Ovarian Res Wang C, Liu L, Hu J, Li X, Li X, Zhu Q, Yang L, Pu K, Li R. PMID: 42374435 [PubMed - as supplied by publisher]
	Toxicity profile and tolerability of immune checkpoint inhibitors for the treatment of early-stage breast cancer: a systematic review and meta-analysis. Breast Dacoregio MI, Rego Castro CED, Mamede I, Rodrigues CG, Thimotheo Batista JP, Michelon I, Ribeiro PZ, Oliveira Junior JR, Bonadio RC, Vilbert M, Barros Costa RL. PMID: 42372581 [PubMed - as supplied by publisher]
	Beyond the first dose: Systematic review on external beam radiotherapy for locoregional breast cancer recurrence. Breast Nano J, Shen Y, Allwohn L, Behzadi ST, Kiesl S, Maier S, Moser R, Zaidi SH, Beddor AN, Amamoo RS, Amamoo RS, Pazos M, Combs SE, Corradini S, Borm K. PMID: 42372580 [PubMed - as supplied by publisher]
	Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence. Breast Sanchez-Bayona R, Anders C, Bartsch R, Cameron DA, Ciruelos EM, Criscitiello C, Duhoux FP, Foukakis T, Frenel JS, Gligorov J, Kaufman PA, Lambertini M, LeVasseur N, Okines A, Penault-Llorca F, Müller V, Blahna MT, Neuberger E, Simon S, Zanucco E, Rosé C, Curigliano G, Harbeck N. PMID: 42372579 [PubMed - as supplied by publisher]
	Treatment of breast cancer brain metastases in the era of novel drugs. Cancer Treat Rev Etessami JD, Dalla Via G, Ferraro E, Trapani D, Curigliano G, Marra A. PMID: 42372577 [PubMed - as supplied by publisher]
	The multifaceted role of bile acids in breast cancer: pathogenesis, therapeutic potential, and drug delivery. PeerJ Yu Q, Ding H, Chen Y, Gao X. PMID: 42371546 [PubMed - indexed for MEDLINE]
	Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation. Breast Cancer (Dove Med Press) Abdel-Razeq H. PMID: 42371537 [PubMed]
	Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice. Bioimpacts Mardi N, Zarebkohan A, Biray-Avci C, Rahbarghazi R, Talebi M, Lotfimehr H, Khavandkari S, Abbasi-Malati Z, Sedghi-Samarkhazan N, Shahriyari E, Khalilnezhad A, Milani M, Nouri M. PMID: 42371526 [PubMed]
	The involvement of circular RNAs in breast cancer metastasis: Insight into EMT-related signaling pathways. Bioimpacts Molavand M, Majidinia M, Yousefi B. PMID: 42371522 [PubMed]
	How to optimise breast cancer staging with contrast-enhanced mammography: current evidence and clinical implications. Insights Imaging Bellini C, Bicchierai G, de Benedetto D, di Naro F, Maiello C, Vidali S, Tonelli P, Vanzi E, Boeri C, Miele V, Nori J. PMID: 42371243 [PubMed]
	Effect of two types of time-restricted eating on glycemic, lipid indices, and weight in women with polycystic ovary syndrome: a randomized controlled trial. Eur J Nutr Aminian M, Hajshafiha M, Heidari M, Daneghian S. PMID: 42371138 [PubMed - indexed for MEDLINE]
	Nutrition interventions in women with polycystic ovary syndrome: a systematic review. Eur J Nutr Akba, Samanc, Öztürk YE. PMID: 42371137 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 331396

Page 1 of 16570



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy